SCHEMBL31685487

SCHEMBL31685487

CN1C(=O)C=CN([C@H]2C[C@H](O)[C@@H](COP(=O)(O)O)O2)C1N

nearest known ligand 0.50

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ TYMS P04818 5/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31685730 0.83 LMNA (0.44) —
SCHEMBL31685787 0.81 P2RY2 (0.47) —
SCHEMBL31685377 0.79 P2RY1 (0.34) —
SCHEMBL25843121 0.74 TYMS (0.44) TYMS
SCHEMBL31685767 0.73 TYMS (0.45) TYMS
SCHEMBL22765896 0.72 TYMS (0.50) TYMS
SCHEMBL31685479 0.72 TYMS (0.55) TYMS
SCHEMBL31685513 0.71 ADORA1 (0.42) —
SCHEMBL31685603 0.70 TYMS (0.53) TYMS
SCHEMBL4321066 0.69 TYMS (0.53) TYMS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250289840-A1 RNA STABILIZING SUBSTANCES AND METHODS OF USE TEAM MEDICAL, LLC 2025-09-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250289840-A1 RNA STABILIZING SUBSTANCES AND METHODS OF USE SYNCRIP, SNRPA, RNASE1 TYMS 3277/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback